• Medetomidine and Xylazine – Current Situation in Canada
• Emergence of Orphines: Novel Synthetic Opioids in Canada
• Border requirements for importing and exporting health products (COVID-19)
• COVID-19: Summary data about travellers, testing and compliance
• Emergence of Desalkylgidazepam: A Novel Benzodiazepine in Canada